Risk Factors for Development of Nontyphoid Salmonella Bacteremia

The objective of this paper was to identify risk factors for nontyphoid Salmonella bacteremia by making a retrospective chart review of 39 patients with nontyphoid Salmonella bacteremia. The control group included 30 patients with positive Salmonella stool culture (gastroenteritis group). Demographi...

Full description

Saved in:
Bibliographic Details
Published in:Clinical pediatrics 2004-11, Vol.43 (9), p.825-829
Main Authors: Grisaru-Soen, Galia, Wysoki, Michael G., Keller, Nathan
Format: Article
Language:English
Subjects:
Antibiotics
Bacteremia - microbiology
Child
Child, Preschool
Diarrhea - microbiology
Epidemiology
Feces - microbiology
Female
Health risk assessment
Humans
Infant
Infant, Newborn
Male
Pediatrics
Retrospective Studies
Risk Factors
Salmonella
Salmonella - classification
Salmonella - isolation & purification
Salmonella Infections - microbiology
Seasons
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The objective of this paper was to identify risk factors for nontyphoid Salmonella bacteremia by making a retrospective chart review of 39 patients with nontyphoid Salmonella bacteremia. The control group included 30 patients with positive Salmonella stool culture (gastroenteritis group). Demographic factors, presenting signs and symptoms, antimicrobial treatment before admission, and microbiologic results were recorded. Nine patients (23%) were excluded owing to recognized risk factors for development of extraintestinal disease. Seventeen cases (57%) occurred during summer time, whereas the gastroenteritis group had a less seasonal tendency. Eighty percent of the patients with Salmonella bacteremia had a previous history of diarrhea. At admission more patients in the bacteremia group were febrile and had leukocytosis (73% vs 33% and 37% vs 20%, respectively). More patients in the bacteremia group had previous antibiotic treatment (57% vs 20%, p
ISSN:0009-9228
1938-2707
DOI:10.1177/000992280404300906